Condition
Graft Survival
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07269041Phase 1Recruiting
Immune Tolerance Induction After Liver Transplantation
NCT07250919Completed
Donor and Recipient Mismatch in Liver Transplantation
NCT07374484Completed
Longitudinal Dynamics of AT1R Antibodies in Kidney Transplant Recipients
NCT02727296Phase 4Completed
Volatile Anesthetic Protection Of Renal Transplants 2
NCT03582436Completed
Rejection Diagnosis in Kidney Transplants Patients
NCT02120157Phase 2Completed
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Showing all 6 trials